Events3rd International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-3 of the event 3rd International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2017
Citation
Franziska Kohl, Michael Gütschow, Fragments of Peptoid 1:Synthesis of N-Substituted Glycine Monomers, in Proceedings of 3rd International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2017, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-3-04706
Share
Email
Facebook
Twitter
LinkedIn

Fragments of Peptoid 1:Synthesis of N-Substituted Glycine Monomers

image
1. Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn
Abstract

Peptoids are N-substituted glycine oligomers comprising multiple biomedical applications. In particular, they are used in nanotechnological approaches. In this context, their application is typically focused on larger oligomers, which form two-dimensional structures, but are difficult to be synthesized. However, a short peptoid of three N-substituted glycine building blocks, referred to as peptoid 1, is known to inhibit the proapoptotic protein APAF1. Herein, we report on the preparation of various peptoidic building blocks of peptoid 1. The synthesis was conducted by alkylation of two different amine components, 2-(2,4-dichlorophenyl)ethylamine and 3,3-diphenylpropylamine with tert-butyl bromoacetate, benzyl bromoacetate, and 2-bromoacetamide, respectively. The resulting glycine derivatives have been characterized by NMR and LC/MS data. The new peptoid units will be provided to biochemical studies, e.g. to the evaluation of protease-inhibiting properties, in order to perform a fragment-based approach.

Keywords
peptoids
building blocks
N-alkylations
Manuscript
Poster
FK_MG_ECMC_final.pdf
A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2
A Synthetic Entry to Amino Acid Derivatives through Davidson-like Heterocyclization